The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer
BeOne Medicines Reaches U.S. Government Agreement to Expand Access to Cancer Medicines
From Poison to Pill: The History and Future of Arsenic Therapy in Leukemia
Servier Pharmaceuticals Is Pleased to Welcome Jerome Klein
Aakash Desai: Top Picks for WCLC 2026
Talha Badar: Azacitidine or Decitabine for Newly Diagnosed TP53-Mutant AML?
Could Olanzapine Change the Way We Prevent Radiation-Induced Nausea?
